Lck is a key target of imatinib and dasatinib in T-cell activation

Research output: Contribution to journalLetterpeer-review

72 Citations (Scopus)
Original languageEnglish
Pages (from-to)896 - 900
Number of pages5
JournalLeukemia
Volume24
Issue number4
DOIs
Publication statusPublished - Apr 2010

Cite this